Notification: The Recombinant Protein Production and Characterization (RPPC) Core has undergone reorganization as of January 2026. The previous Macromolecular X-Ray Crystallography Core has been integrated into the RPPC Core and it has been renamed “Recombinant Protein Production, Characterization and Crystallography (RPPCC) Core.” The merged core provides all the same support services as previously but under a more efficient and comprehensive operational approach.
About the Core
The Recombinant Protein Production, Characterization, and Crystallography (RPPCC) Core is an Institutional Advanced Technology Core available to all Baylor College of Medicine investigators on a fee-for-service basis. The core has been reorganized by merging two existing cores - the Recombinant Protein Production and Characterization core and Macromolecular X-ray Crystallography core - to streamline protein production, biophysical characterization, and high resolution structure determination using X-ray crystallography.
The mission of the core is to provide high-quality purified protein products in sufficient quantities for various experimental applications including in vitro biochemical and biophysical analysis, macromolecular structure and as therapeutic targets for drug development projects. The major core services are the following:
- Up-front consultation on experimental design and assistance with construction of various recombinant protein expression vectors.
- Expression of recombinant proteins in three different overexpression system options including: E. Coli, baculovirus (SF9 insect cells), and mammalian cells (Expi293F).
- Purification of recombinant proteins by affinity and conventional chromatography procedures and quality control analysis of purified products. This includes investigator proteins of interest and monoclonal antibodies from existing hybridoma cell lines.
- Molecular Characterization of purified proteins by various biophysical methods.
- High resolution structure determination of macromolecules using X-ray crystallography.
Core services can be requested in iLabs.
Getting Started
If you have questions and plan to make use of the core, please email atc-protein-mab@bcm.edu. We can offer consultation in Zoom or in-person meeting.
Services
Selected Publications Supported by the Core
2025
Pham S, Zhao B, Neetu N, Sankaran B, Patil K, Ramani S, Song Y, Estes MK, Palzkill T, Prasad BVV. Conformational flexibility is a critical factor in designing broad-spectrum human norovirus protease inhibitors. J Virol. 2025;99(2):e0175724. doi: 10.1128/jvi.01757-24. PMID: 39873493; PMCID: PMC11852804.
2024
Jimmidi R, Monsivais D, Ta HM, Sharma KL, Bohren KM, Chamakuri S, Liao Z, Li F, Hakenjos JM, Li JY, Mishina Y, Pan H, Qin X, Robers MB, Sankaran B, Tan Z, Tang S, Vasquez YM, Wilkinson J, Young DW, Palmer SS, MacKenzie KR, Kim C, Matzuk MM. Discovery of highly potent and ALK2/ALK1 selective kinase inhibitors using DNA-encoded chemistry technology. Proc Natl Acad Sci U S A. 2024;121(47) PMID: 39541346; PMCID: PMC11588046.
Judge A, Sankaran B, Hu L, Palaniappan M, Birgy A, Prasad BVV, & Palzkill T, Network of epistatic interactions in an enzyme active site revealed by large-scale deep mutational scanning, Proc. Natl. Acad. Sci. U.S.A. 2024;121 (12) e2313513121, PMCID: PMC10962969.
Md Ashraf-Uz-Zaman, Teck Khiang Chua, Xin Li, Yuan Yao, Bala Krishna Moku, Chandra Bhushan Mishra, Vasanthi Avadhanula, Pedro A. Piedra, and Yongcheng Song. Design, Synthesis, X-ray Crystallography, and Biological Activities of Covalent, Non-Peptidic Inhibitors of SARS-CoV-2 Main Protease ACS Infectious Diseases 2024; 10 (2), 715-731 PMCID: PMC 10922772.
2022
Gu T, Hao D, Woo J, Huang TW, Guo L, Lin X, Guzman AG, Tovy A, Rosas C, Jeong M, Zhou Y, Deneen B, Huang Y, Li W, Goodell MA. The disordered N-terminal domain of DNMT3A recognizes H2AK119ub and is required for postnatal development. Nat Genet. 2022 May;54(5):625-636. doi: 10.1038/s41588-022-01063-6. Epub 2022 May 9. PMID: 35534561; PMCID: PMC9295050.
2021
Versteeg L, Adhikari R, Poveda C, Villar-Mondragon MJ, Jones KM, Hotez PJ, Bottazzi ME, Tijhaar E, Pollet J. Location and expression kinetics of Tc24 in different life stages of Trypanosoma cruzi. PLoS Negl Trop Dis. 2021 Sep 3;15(9):e0009689. doi: 10.1371/journal.pntd.0009689. PMID: 34478444; PMCID: PMC8415617.
Alvarado G, Salmen W, Ettayebi K, Hu L, Sankaran B, Estes MK, Venkataram Prasad BV, Crowe JE Jr. Broadly cross-reactive human antibodies that inhibit genogroup I and II noroviruses. Nat Commun. 2021 Jul 4;12(1):4320. doi: 10.1038/s41467-021-24649-w. Erratum in: Nat Commun. 2021 Oct 14;12(1):6090. PMID: 34262046; PMCID: PMC8280134.
Strutzenberg TS, Zhu Y, Novick SJ, Garcia-Ordonez RD, Doebelin C, He Y, Chang MR, Kamenecka TM, Edwards DP, Griffin PR. Conformational Changes of RORγ During Response Element Recognition and Coregulator Engagement. J Mol Biol. 2021 Nov 5;433(22):167258. doi: 10.1016/j.jmb.2021.167258. Epub 2021 Sep 20. PMID: 34547329; PMCID: PMC8556364.
2020
Kumar D, Yu X, Crawford SE, Moreno R, Jakana J, Sankaran B, Anish R, Kaundal S, Hu L, Estes MK, Wang Z, Prasad BVV. 2.7 Å cryo-EM structure of rotavirus core protein VP3, a unique capping machine with a helicase activity. Sci Adv. 2020 Apr 15;6(16):eaay6410. doi: 10.1126/sciadv.aay6410. PMID: 32494598; PMCID: PMC7159914.
Yu X, Yi P, Hamilton RA, Shen H, Chen M, Foulds CE, Mancini MA, Ludtke SJ, Wang Z, O'Malley BW. Structural Insights of Transcriptionally Active, Full-Length Androgen Receptor Coactivator Complexes. Mol Cell, 2020 Sep 3;79(5):812-823. doi: 10.1016/j.molcel. 2020.06.031. Epub 2020 Jul 14. PMID: 32668201; PMCID: PMC7483370.
Bimler L, Ronzulli SL, Song AY, Johnson SK, Jones CA, Kim T, Le DT, Tompkins SM, Paust S. Matrix Protein 2 Extracellular Domain-Specific Monoclonal Antibodies Are an Effective and Potentially Universal Treatment for Influenza A. J Virol. 2020 Dec 2:JVI.01027-20. doi: 10.1128/JVI.01027-20. Epub ahead of print. Erratum in: J Virol. 2022 Oct 12;96(19):e0135822. PMID: 33268521; PMCID: PMC8092830.
Chen S, Jiao L, Liu X, Yang X, Liu X. A Dimeric Structural Scaffold for PRC2-PCL Targeting to CpG Island Chromatin. Mol Cell. 2020 Mar 19;77(6):1265-1278. doi: 10.1016/j.molcel. 2019.12.019. Epub 2020 Jan 17. PMID: 31959557; PMCID: PMC7571800.
Fuery A, Pursell T, Tan J, Peng R, Burbelo PD, Hayward GS, Ling PD. Lethal Hemorrhagic Disease and Clinical Illness Associated with Elephant Endotheliotropic Herpesvirus 1 Are Caused by Primary Infection: Implications for the Detection of Diagnostic Proteins. J Virol. 2020 Jan 17;94(3):e01528-19. doi: 10.1128/JVI.01528-19. PMID: 31723022; PMCID: PMC7000966.
2019
Lee ME, Dou X, Zhu Y, Phillips KJ. Refolding Proteins from Inclusion Bodies using Differential Scanning Fluorimetry Guided (DGR) Protein Refolding and MeltTraceur Web. Curr Protoc Mol Biol. 2019 Jan;125(1):e78. doi: 10.1002/cpmb.78. Epub 2018 Oct 29. PMID: 30371021.
Vossaert L, Wang Q, Salman R, McCombs AK, Patel V, Qu C, Mancini MA, Edwards DP, Malovannaya A, Liu P, Shaw CA, Levy B, Wapner RJ, Bi W, Breman AM, Van den Veyver IB, Beaudet AL. Validation Studies for Single Circulating Trophoblast Genetic Testing as a Form of Noninvasive Prenatal Diagnosis. Am J Hum Genet. 2019 Dec 5;105(6):1262-1273. doi: 10.1016/j.ajhg.2019.11.004. Epub 2019 Nov 27. PMID: 31785788; PMCID: PMC6904821.






